Mobidiag, a Finnish-French developer of innovative molecular diagnostic tests and instrumentation, has signed a definitive agreement to be acquired by Hologic, a women’s health specialist, for approximately €668 million.
Show CommentsClose Comments
Mobidiag, a Finnish-French developer of innovative molecular diagnostic tests and instrumentation, has signed a definitive agreement to be acquired by Hologic, a women’s health specialist, for approximately €668 million.